Literature DB >> 23211537

Kindlin-2 promotes genome instability in breast cancer cells.

Ting Zhao1, Lizhao Guan, Yu Yu, Xuelian Pei, Jun Zhan, Ling Han, Yan Tang, Feng Li, Weigang Fang, Hongquan Zhang.   

Abstract

Kindlin-2, as a focal adhesion protein, has been found to regulate tumor progression. However, the mechanism underlying Kindlin-2 regulation of tumor progression is largely unknown. Here, we report that Kindlin-2 regulates breast cancer cell proliferation, apoptosis and chromosomal abnormalities in both gain and loss of function assays. Functionally, overexpression of Kindlin-2 promotes tumor formation in implanted xenograft while knockdown of Kindlin-2 inhibits tumor growth in mice. Mechanistically, an array-based comparative genomic hybridization and karyotype analyses indicate that ectopic expression of Kindlin-2 leads to genome instability in breast cancer cells. Our data suggest a novel mechanism that Kindlin-2 regulates breast cancer progression by inducing genome instability.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23211537     DOI: 10.1016/j.canlet.2012.11.043

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  Mig-2 attenuates cisplatin-induced apoptosis of human glioma cells in vitro through AKT/JNK and AKT/p38 signaling pathways.

Authors:  Yun-wei Ou; Zi-tong Zhao; Chuan-yue Wu; Bai-nan Xu; Yong-mei Song; Qi-min Zhan
Journal:  Acta Pharmacol Sin       Date:  2014-08-25       Impact factor: 6.150

2.  Kindlin-2 inhibited the growth and migration of colorectal cancer cells.

Authors:  Yuanyuan Ren; Hongsong Jin; Zhidong Xue; Qianlang Xu; Songhua Wang; Guojun Zhao; Junxing Huang; He Huang
Journal:  Tumour Biol       Date:  2015-01-30

3.  Increased expression of kindlin 2 in luteinized granulosa cells correlates with androgen receptor level in patients with polycystic ovary syndrome having hyperandrogenemia.

Authors:  Mei Yang; Juan Du; Danyu Lu; Caixia Ren; Huan Shen; Jie Qiao; Xi Chen; Hongquan Zhang
Journal:  Reprod Sci       Date:  2013-12-13       Impact factor: 3.060

4.  Differences in self-association between kindlin-2 and kindlin-3 are associated with differential integrin binding.

Authors:  Yasmin A Kadry; Eesha M Maisuria; Clotilde Huet-Calderwood; David A Calderwood
Journal:  J Biol Chem       Date:  2020-06-16       Impact factor: 5.157

5.  Kindlin-2 Regulates the Growth of Breast Cancer Tumors by Activating CSF-1-Mediated Macrophage Infiltration.

Authors:  Khalid Sossey-Alaoui; Elzbieta Pluskota; Katarzyna Bialkowska; Dorota Szpak; Yvonne Parker; Chevaun D Morrison; Daniel J Lindner; William P Schiemann; Edward F Plow
Journal:  Cancer Res       Date:  2017-07-07       Impact factor: 12.701

6.  YBX1 knockdown induces renal cell carcinoma cell apoptosis via Kindlin-2.

Authors:  Qiqi Cui; Chao Wang; Shuang Liu; Runxuan Du; Shaoping Tian; Ruibing Chen; Hua Geng; Saravanan Subramanian; Yuanjie Niu; Yong Wang; Dan Yue
Journal:  Cell Cycle       Date:  2021-10-28       Impact factor: 4.534

7.  Kindlin-2 promotes Src-mediated tyrosine phosphorylation of androgen receptor and contributes to breast cancer progression.

Authors:  Luyao Ma; Yeteng Tian; Tao Qian; Wenjun Li; Chengmin Liu; Bizhu Chu; Qian Kong; Renwei Cai; Panzhu Bai; Lisha Ma; Yi Deng; Ruijun Tian; Chuanyue Wu; Ying Sun
Journal:  Cell Death Dis       Date:  2022-05-20       Impact factor: 9.685

Review 8.  Role of Kindlin-2 in cancer progression and metastasis.

Authors:  Wei Wang; Urna Kansakar; Vesna Markovic; Khalid Sossey-Alaoui
Journal:  Ann Transl Med       Date:  2020-07

9.  Mitotic perturbations induced by Nek2 overexpression require interaction with TRF1 in breast cancer cells.

Authors:  Jaehyung Lee; Lauren Gollahon
Journal:  Cell Cycle       Date:  2013-09-30       Impact factor: 4.534

Review 10.  Late-Onset Alzheimer's Disease Genes and the Potentially Implicated Pathways.

Authors:  Samantha L Rosenthal; M Ilyas Kamboh
Journal:  Curr Genet Med Rep       Date:  2014-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.